166 related articles for article (PubMed ID: 30549305)
1. For the many: permitting deceased donor kidney transplantation across low-titre blood group antibodies can reduce wait times for blood group B recipients, and improve the overall number of 000MM transplants - a multicentre observational cohort study.
Manook M; Mumford L; Barnett ANR; Osei-Bordom D; Sandhu B; Veniard D; Maggs T; Shaw O; Kessaris N; Dorling A; Shah S; Mamode N
Transpl Int; 2019 Apr; 32(4):431-442. PubMed ID: 30549305
[TBL] [Abstract][Full Text] [Related]
2. Distribution of ABO blood group antibody titers in pediatric patients awaiting renal transplantation: implications for organ allocation policy.
Barnett AN; Hudson A; Hadjianastassiou VG; Marks SD; Reid CJ; Maggs TP; Vaughan R; Mamode N
Transplantation; 2012 Aug; 94(4):362-8. PubMed ID: 22820700
[TBL] [Abstract][Full Text] [Related]
3. ABO-incompatible matching significantly enhances transplant rates in kidney paired donation.
Ferrari P; Hughes PD; Cohney SJ; Woodroffe C; Fidler S; D'Orsogna L
Transplantation; 2013 Nov; 96(9):821-6. PubMed ID: 23860086
[TBL] [Abstract][Full Text] [Related]
4. The 'blood group O problem' in kidney transplantation--time to change?
Glander P; Budde K; Schmidt D; Fuller TF; Giessing M; Neumayer HH; Liefeldt L
Nephrol Dial Transplant; 2010 Jun; 25(6):1998-2004. PubMed ID: 20100733
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.
Bryan CF; Nelson PW; Shield CF; Ross G; Warady B; Murillo D; Winklhofer FT
Clin Transpl; 2004; ():127-33. PubMed ID: 16704145
[TBL] [Abstract][Full Text] [Related]
6. Estimating Waiting Time for Deceased Donor Renal Transplantion in the Era of New Kidney Allocation System.
Torlak F; Ayvaci MU; Ahsen ME; Arce C; Vazquez MA; Tanriover B
Transplant Proc; 2016; 48(6):1916-9. PubMed ID: 27569922
[TBL] [Abstract][Full Text] [Related]
7. The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization.
Kayler LK; Segev DL
Am J Kidney Dis; 2010 Jul; 56(1):95-101. PubMed ID: 20347513
[TBL] [Abstract][Full Text] [Related]
8. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
[TBL] [Abstract][Full Text] [Related]
9. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.
Orandi BJ; Luo X; Massie AB; Garonzik-Wang JM; Lonze BE; Ahmed R; Van Arendonk KJ; Stegall MD; Jordan SC; Oberholzer J; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Nelson PW; Wellen J; Bozorgzadeh A; Gaber AO; Montgomery RA; Segev DL
N Engl J Med; 2016 Mar; 374(10):940-50. PubMed ID: 26962729
[TBL] [Abstract][Full Text] [Related]
10. Broadened Allocation of Pancreas Transplants Across Compatible ABO Blood Types.
Fridell JA; Gustafson SK; Thompson BW; Fox AC; Prentice MA; Curry MA; Odorico JS
Transplant Proc; 2017 Dec; 49(10):2318-2323. PubMed ID: 29198669
[TBL] [Abstract][Full Text] [Related]
11. First Report on the OPTN National Variance: Allocation of A2 /A2 B Deceased Donor Kidneys to Blood Group B Increases Minority Transplantation.
Williams WW; Cherikh WS; Young CJ; Fan PY; Cheng Y; Distant DA; Bryan CF
Am J Transplant; 2015 Dec; 15(12):3134-42. PubMed ID: 26372745
[TBL] [Abstract][Full Text] [Related]
12. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.
Bryan CF; Winklhofer FT; Murillo D; Ross G; Nelson PW; Shield CF; Warady BA
Transplantation; 2005 Jul; 80(1):75-80. PubMed ID: 16003236
[TBL] [Abstract][Full Text] [Related]
13. The OPTN/UNOS Renal Transplant Registry.
Cecka JM
Clin Transpl; 2005; ():1-16. PubMed ID: 17424721
[TBL] [Abstract][Full Text] [Related]
14. Primum non nocere: avoiding harm to vulnerable wait list candidates in an indirect kidney exchange.
Zenios SA; Woodle ES; Ross LF
Transplantation; 2001 Aug; 72(4):648-54. PubMed ID: 11544425
[TBL] [Abstract][Full Text] [Related]
15. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
16. A2/A2B Deceased Donor Kidney Transplantation Using A2 Titers Improves Access to Kidney Transplantation: A Single-Center Study.
Lum EL; Pirzadeh A; Datta N; Lipshutz GS; McGonigle AM; Hamiduzzaman A; Bjelajac N; Hale-Durbin B; Bunnapradist S
Kidney Med; 2024 Jul; 6(7):100843. PubMed ID: 38947773
[TBL] [Abstract][Full Text] [Related]
17. New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.
Hickey MJ; Zheng Y; Valenzuela N; Zhang Q; Krystal C; Lum E; Tsai EW; Lipshutz GS; Gritsch HA; Danovitch G; Veale J; Gjertson D; Cecka M; Reed EF
Hum Immunol; 2017 Jan; 78(1):41-48. PubMed ID: 27818166
[TBL] [Abstract][Full Text] [Related]
18. UK Renal Registry 16th annual report: chapter 4 demography of patients waitlisted for renal transplantation in the UK: national and centre-specific analyses.
Pruthi R; Hilton R; Pankhurst L; Mamode N; Hudson A; Roderick P; Ravanan R
Nephron Clin Pract; 2013; 125(1-4):81-98. PubMed ID: 24662168
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience.
Hurst FP; Sajjad I; Elster EA; Falta EM; Patel P; Abbott KC; Agodoa LY; Jindal RM
Transplantation; 2010 Jun; 89(11):1396-402. PubMed ID: 20354481
[TBL] [Abstract][Full Text] [Related]
20. Access to kidney transplantation among pediatric candidates with prior solid organ transplants in the United States.
Husain SA; King KL; Owen-Simon NL; Fernandez HE; Ratner LE; Mohan S
Pediatr Transplant; 2022 Sep; 26(6):e14303. PubMed ID: 35615911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
